Helge Bischoff

Helge Bischoff

UNVERIFIED PROFILE

Are you Helge Bischoff?   Register this Author

Register author
Helge Bischoff

Helge Bischoff

Publications by authors named "Helge Bischoff"

Are you Helge Bischoff?   Register this Author

32Publications

873Reads

14Profile Views

A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer.

Invest New Drugs 2019 Nov 9. Epub 2019 Nov 9.

Department of Thoracic Oncology, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg University Hospital, 69126, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00873-6DOI Listing
November 2019

Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer.

J Cancer Res Clin Oncol 2018 Dec 22;144(12):2457-2463. Epub 2018 Sep 22.

Department of Hematology and Oncology, Johann Wolfgang Goethe University Hospital of Frankfurt, Theodor Stern Kai 7, 60596, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-018-2754-x
Publisher Site
http://dx.doi.org/10.1007/s00432-018-2754-xDOI Listing
December 2018

Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.

Lung Cancer 2018 05 6;119:48-55. Epub 2018 Mar 6.

Translational Research Unit, Thoraxklinik at Heidelberg University Hospital, Germany; Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Member of the German Center for Lung Research (DZL), Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.03.002DOI Listing
May 2018

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

N Engl J Med 2018 May 16;378(22):2078-2092. Epub 2018 Apr 16.

From NYU Perlmutter Cancer Center, New York (L.G.); Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria (D.R.-A.), Hospital Universitario Central de Asturias, Oviedo (E.E.), Vall d'Hebron University, Vall d'Hebron Institute of Oncology, Barcelona (E.F.), and Fundación Jiménez Díaz (M.D.) and Hospital Universitario Quirón Madrid (B.R.-V.), Madrid - all in Spain; Karmanos Cancer Institute, Detroit (S.G.); Integrated Health and Social Services Centres, Montérégie Centre, Greenfield Park, QC (F.D.A.), and Sunnybrook Health Sciences Centre, Toronto (S.Y.-S.C.) - both in Canada; Southern Medical Day Care Centre, Wollongong, NSW (P.C.), Epworth Healthcare, Richmond, VIC (R.R.J.), Westmead Hospital and University of Sydney, Sydney (R.H.), and Chris O'Brien Lifehouse, Camperdown, NSW (M.B.) - all in Australia; Otto Wagner Hospital, Vienna (M.J.H.); Sanford Health, Sioux Falls, SD (S.F.P.); Thoraxklinik, Heidelberg (H.G.B.), and LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany; Davidoff Cancer Center, Tel Aviv University, Petah Tikva, Israel (N.P.); Ospedale Policlinico San Martino, Genoa (F.G.), University of Turin, Azienda Ospedaliero-Universitaria San Luigi, Orbassano (S.N.), and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - all in Italy; David Geffen School of Medicine at UCLA, Los Angeles (E.B.G.); Kansai Medical University Hospital, Osaka, Japan (T.K.); Moffitt Cancer Center, Tampa, FL (J.E.G.); and Merck, Kenilworth, NJ (J.V., Z.W., J.Y., H.R., M.C.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801005DOI Listing
May 2018

Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer.

Clin Lung Cancer 2017 07 2;18(4):e267-e271. Epub 2016 Dec 2.

Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.11.012DOI Listing
July 2017

Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer.

Anticancer Res 2014 Jul;34(7):3707-13

Department of Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
July 2014

Characteristics of lung cancer after a previous malignancy.

Respir Med 2014 Jun 5;108(6):910-7. Epub 2014 Mar 5.

Department of Thoracic Oncology, Thoraxklinik at the University of Heidelberg, 69126 Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2014.02.015DOI Listing
June 2014

Characteristics and outcome of patients with second primary lung cancer.

Eur Respir J 2013 Dec 11;42(6):1668-76. Epub 2012 Oct 11.

Thoraxklinik, University of Heidelberg, Heidelberg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00022512DOI Listing
December 2013

Why do nonsurvivors from community-acquired pneumonia not receive ventilatory support?

Lung 2013 Aug 5;191(4):417-24. Epub 2013 May 5.

HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00408-013-9467-3DOI Listing
August 2013

Targeting the epidermal growth factor receptor in non-small cell lung cancer.

Onkologie 2010 26;33(12):704-9. Epub 2010 Nov 26.

Clinic for Thoracic Diseases, University of Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322214DOI Listing
May 2011

Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.

Lung Cancer 2010 Aug;69 Suppl 1:S18-23

Thoraxklinik Heidelberg GmbH, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0169-5002(10)70134-3DOI Listing
August 2010

Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome.

Chest 2006 Jun;129(6):1570-6

Novartis Chair and Director of Imaging Research, Department of Radiology, The Ohio State University, University Hospitals, 657 Means Hall, 1654 Upham Dr, Columbus, OH 43210-1228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.129.6.1570DOI Listing
June 2006

[Pro and contra: coding of bacteria].

Med Klin (Munich) 2005 Aug;100(8):502-4

MediClin AG, Stab Strategische Planung, Offenburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00063-005-1064-7DOI Listing
August 2005